| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Karlin Daniel is a Chief Medical Officer at MNMD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $14.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | DFTX Definium Therapeutics, Inc. | Chief Medical Officer | Sell | 8,018 | $18.47 | $148,092.46 | -1.9% | - | - | |
| Dec 26, 2025 | Chief Medical Officer | Sell | 5,600 | $13.15 | $73,622.64 | -1.3% | - | - | ||
| Sep 25, 2025 | Chief Medical Officer | Sell | 7,704 | $9.77 | $75,268.08 | -1.8% | - | - | ||
| Jun 25, 2025 | Chief Medical Officer | Sell | 7,848 | $6.80 | $53,366.40 | -1.8% | - | - | ||
| Mar 25, 2025 | Chief Medical Officer | Sell | 6,836 | $6.74 | $46,074.64 | -1.5% | - | - | ||
| Dec 26, 2024 | Chief Medical Officer | Sell | 6,643 | $7.43 | $49,357.49 | -1.9% | - | - | ||
| Sep 25, 2024 | Chief Medical Officer | Sell | 6,871 | $5.98 | $41,088.58 | -2.0% | - | - | ||
| Jun 25, 2024 | Chief Medical Officer | Sell | 6,925 | $7.22 | $49,998.50 | -1.9% | - | - | ||
| Mar 25, 2024 | Chief Medical Officer | Sell | 6,578 | $9.50 | $62,491.00 | -1.8% | - | - | ||
| Dec 26, 2023 | Chief Medical Officer | Sell | 6,774 | $3.63 | $24,589.62 | -1.8% | - | - |